Literature DB >> 20136879

Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS).

Felicidade Santiago1, Margarida Gonçalo, Ricardo Vieira, Sónia Coelho, Américo Figueiredo.   

Abstract

BACKGROUND: In some patterns of cutaneous adverse drug reactions, and depending on the culprit drug, patch testing has been helpful in confirming its cause. Its value in Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) has not been established in a large cohort of patients.
OBJECTIVE: The aim of the present study is to evaluate the safety and usefulness of patch testing in DRESS. PATIENTS/
METHODS: Between January 1998 and December 2008, we studied 56 patients with DRESS induced by antiepileptic agents in 33 patients (59%), allopurinol in 19 (34%) and sulfasalazine, cotrimoxazole, tenoxicam, and amoxicillin in 1 patient each (7%).
RESULTS: A positive patch test reaction was observed in 18 patients (32.1%), of which 17 were with antiepileptics and 1 with tenoxicam. In the antiepileptic group, carbamazepine alone was responsible for 13 of 17 positive reactions (76.5%). Patch tests with allopurinol and its metabolite were negative in all cases attributed to this drug.
CONCLUSIONS: In this study, patch testing was a safe and useful method in confirming the culprit drug in DRESS induced by antiepileptic drugs, whereas it had no value in DRESS induced by allopurinol. The pathogenesis of DRESS is not yet entirely clarified, but positive patch tests suggest a drug-dependent delayed hypersensitivity mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136879     DOI: 10.1111/j.1600-0536.2009.01659.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  20 in total

1.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

2.  Highly Probable Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Lenalidomide.

Authors:  Anusha Shanbhag; E Ryan Pritchard; Kshitij Chatterjee; Drayton A Hammond
Journal:  Hosp Pharm       Date:  2017-07-18

3.  Evaluation of drug patch tests in children.

Authors:  Şule Büyük Yaytokgil; Hakan Güvenir; İlknur Külhaş Celík; Özge Yilmaz Topal; Betül Karaatmaca; Ersoy Civelek; Müge Toyran; Emine Dibek Misirlioğlu
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

Review 4.  Recent advances in the understanding of severe cutaneous adverse reactions.

Authors:  N R Adler; A K Aung; E N Ergen; J Trubiano; M S Y Goh; E J Phillips
Journal:  Br J Dermatol       Date:  2017-09-29       Impact factor: 9.302

5.  DRESS characteristics according to the causative medication.

Authors:  A Chaabane; H Ben Romdhane; N Ben Fadhel; N Ben Fredj; H Ammar; N Boughattas; Z Chadly; K Aouam
Journal:  Eur J Clin Pharmacol       Date:  2022-06-20       Impact factor: 3.064

Review 6.  Allopurinol hypersensitivity: investigating the cause and minimizing the risk.

Authors:  Lisa K Stamp; Richard O Day; James Yun
Journal:  Nat Rev Rheumatol       Date:  2015-09-29       Impact factor: 20.543

7.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Patient with Bipolar Disorder: A Case Report.

Authors:  Snehil Gupta; Raman Deep; Sudhir Kumar Khandelwal; Binod K Khaitan
Journal:  Indian J Psychol Med       Date:  2021-02-22

8.  A case of allopurinol-induced fixed drug eruption confirmed with a lymphocyte transformation test.

Authors:  Min-Hye Kim; Eun-Jin Shim; Jae-Woo Jung; Seong-Wook Sohn; Hye-Ryun Kang
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-29       Impact factor: 5.764

Review 9.  Contact dermatitis.

Authors:  Pamela L Scheinman; Marc Vocanson; Jacob P Thyssen; Jeanne Duus Johansen; Rosemary L Nixon; Kate Dear; Nina C Botto; Johanna Morot; Ari M Goldminz
Journal:  Nat Rev Dis Primers       Date:  2021-05-27       Impact factor: 52.329

Review 10.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.